Legal Representation
Attorney
Michael H. Jacobs
USPTO Deadlines
Next Deadline
948 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-02-15)
Due Date
February 15, 2028
Grace Period Ends
August 15, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
50 events| Date | Code | Type | Description |
|---|---|---|---|
| Jul 19, 2022 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Jul 19, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Jul 19, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Jul 19, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Jul 19, 2022 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Feb 15, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Jan 14, 2022 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Jan 13, 2022 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Dec 22, 2021 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Dec 22, 2021 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE |
| Nov 30, 2021 | EISU | I | TEAS STATEMENT OF USE RECEIVED |
| Nov 30, 2021 | IUAF | S | USE AMENDMENT FILED |
| May 22, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| May 20, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| May 20, 2021 | EXT3 | S | SOU EXTENSION 3 FILED |
| May 20, 2021 | EX3G | S | SOU EXTENSION 3 GRANTED |
| Apr 7, 2021 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Apr 7, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Apr 7, 2021 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Nov 26, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Nov 24, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Nov 24, 2020 | EXT2 | S | SOU EXTENSION 2 FILED |
| Nov 24, 2020 | EX2G | S | SOU EXTENSION 2 GRANTED |
| Sep 1, 2020 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Sep 1, 2020 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Sep 1, 2020 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Jun 4, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Jun 2, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Jun 2, 2020 | EXT1 | S | SOU EXTENSION 1 FILED |
| Jun 2, 2020 | EX1G | S | SOU EXTENSION 1 GRANTED |
| May 26, 2020 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| May 26, 2020 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| May 26, 2020 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| May 26, 2020 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| May 26, 2020 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Dec 3, 2019 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Oct 8, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Oct 8, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Sep 18, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Sep 4, 2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Sep 4, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Sep 4, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Sep 4, 2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Mar 30, 2019 | DOCK | D | ASSIGNED TO EXAMINER |
| Mar 30, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Mar 30, 2019 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Mar 30, 2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Feb 15, 2019 | AMPX | O | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED |
| Feb 12, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Feb 11, 2019 | ALIE | A | ASSIGNED TO LIE |
Detailed Classifications
Class 001
Antibodies for scientific and research purposes
First Use Anywhere:
Sep 29, 2021
First Use in Commerce:
Sep 29, 2021
Class 005
Antibody therapeutic preparations for medical purposes
First Use Anywhere:
Sep 29, 2021
First Use in Commerce:
Sep 29, 2021
Classification
International Classes
001
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"THERAPEUTICS"